Nov 4, 2022
FDA
The new article highlights the key points to be taken into consideration with respect to endpoints in clinical studies. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has...
Read More
Nov 4, 2022
FDA
The new article highlights the main points related to the assessment of applicable risk, as well as the concept of direct benefit for study participants. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere...
Read More
Nov 4, 2022
FDA
The new article covers the aspects related to stratification for subject selection, as well as to site selection in the context of pivotal clinical investigations. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in...
Read More
Nov 3, 2022
FDA
The new article describes in detail the principle of necessity and the way it should be applied. The article also covers the aspects related to risk categories for interventions or procedures without a prospect of direct benefit. Table of Contents The Food and Drug...
Read More
Nov 3, 2022
FDA
The new article highlights the key points related to the study objectives and subject selection in the context of pivotal clinical investigations. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of...
Read More